{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:42:09Z","timestamp":1785235329865,"version":"3.55.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Region Sk\u00e5ne county council"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background\/Aim<\/jats:title>\n<jats:p>Opioid overdose deaths have increased in Sweden and other developed countries in recent decades, despite increased treatment efforts and harm-reduction interventions. Further knowledge in this field is needed if this trend is to be reversed. Previous research suggests that mental health and patterns of prescription of opioids and other prescription drugs are associated with increased opioid-related mortality. The present study therefore aimed to investigate what drugs were prescribed during the last six months of life to individuals with a history of illicit substance use who died with opioids present in their blood, the relationship between drugs prescribed and drugs found in blood at time of death, and if prescription of specific drugs was temporally associated with death.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This was a retrospective, register-based observational study that utilized data from the National Board of Forensic Medicine, the Prescribed Drug Registry, regional health care services, and municipal social services. We used conditional logistic regression to find temporal associations between the prescription and dispensing of drugs and time of death.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Prescription and dispensing of alprazolam and diazepam were temporally associated with death. The most frequently dispensed drugs were zopiclone, pregabalin, methylphenidate, diazepam and oxycodone. Methadone, alprazolam, and buprenorphine were the drugs most often found in the blood. Opioids and tranquilizers in combination were found in a vast majority of deaths, and prescription data suggested that the use of these drugs was illicit in a majority of cases.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Prescription of certain drugs, especially alprazolam and diazepam, should be made with great caution to patients with a history of illicit substance use or concurrent use of opioids.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0285583","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T18:04:27Z","timestamp":1685556267000},"page":"e0285583","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Drug prescriptions preceding opioid-related deaths\u2013a register study in forensic autopsy patients"],"prefix":"10.1371","volume":"18","author":[{"given":"Jonatan","family":"Walde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5800-8975","authenticated-orcid":true,"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"pone.0285583.ref001","volume-title":"OECD Health Policy Studies.","author":"OECD","year":"2019"},{"key":"pone.0285583.ref002","doi-asserted-by":"crossref","first-page":"j4792","DOI":"10.1136\/bmj.j4792","article-title":"Overprescribing is major contributor to opioid crisis","volume":"359","author":"MA Makary","year":"2017","journal-title":"BMJ"},{"issue":"2013","key":"pone.0285583.ref003","first-page":"17","volume":"1","author":"Muhuri","journal-title":"M. Christine Davies. \u201cCBHSQ data review.\u201d Center for Behavioral Health Statistics and Quality, SAMHSA"},{"issue":"2","key":"pone.0285583.ref004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1515\/sjpain-2018-0307","article-title":"Prescribed opioid analgesic use developments in three Nordic countries, 2006\u20132017","volume":"19","author":"AE Muller","year":"2019","journal-title":"Scandinavian Journal of Pain"},{"issue":"4","key":"pone.0285583.ref005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3122\/jabfm.2017.04.170112","article-title":"Prescription Opioid Use among Adults with Mental Health Disorders in the United States.","volume":"30","author":"MA Davis","year":"2017","journal-title":"J Am Board Fam Med"},{"issue":"5","key":"pone.0285583.ref006","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk Factors for Opioid-Use Disorder and Overdose.","volume":"125","author":"LR Webster","year":"2017","journal-title":"Anesthesia and analgesia."},{"issue":"8","key":"pone.0285583.ref007","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11606-015-3199-4","article-title":"Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and\/or Sedative-Hypnotics: Interactions with Mental Health Disorders.","volume":"30","author":"BJ Turner","year":"2015","journal-title":"J Gen Intern Med"},{"key":"pone.0285583.ref008","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","author":"EC Sun","year":"2017","journal-title":"BMJ"},{"issue":"jun10 9","key":"pone.0285583.ref009","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"TW Park","year":"2015","journal-title":"BMJ"},{"key":"pone.0285583.ref010","article-title":"Cohort Study of the Impact of High-dose Opioid Analgesics on Overdose Mortality","author":"N Dasgupta","year":"2015","journal-title":"Pain Medicine"},{"key":"pone.0285583.ref011","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/j.1526-4637.2011.01134.x","article-title":"An analysis of the root causes for opioid-related overdose deaths in the United States","volume":"122","author":"LR Webster","year":"2011","journal-title":"Pain medicine (Malden, Mass)."},{"issue":"8","key":"pone.0285583.ref012","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1360-0443.2004.00790.x","article-title":"A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths.","volume":"99","author":"S Pirnay","year":"2004","journal-title":"Addiction."},{"key":"pone.0285583.ref013","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment\u2014A nation-wide register-based open cohort study","volume":"174","author":"T Abrahamsson","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"pone.0285583.ref014","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/j.pain.0000000000000892","article-title":"Polysubstance use and misuse or abuse of prescription opioid analgesics","volume":"158","author":"KI Morley","year":"2017","journal-title":"PAIN"},{"issue":"6","key":"pone.0285583.ref015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/dar.12841","article-title":"Prescribed sedative and other psychotropic medication use among clients attending alcohol and other drug treatment","volume":"37","author":"JA Foulds","year":"2018","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"pone.0285583.ref016","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-016-0881-y","article-title":"Benzodiazepine prescription for patients in treatment for drug use disorders: a nationwide cohort study in Denmark, 2000\u20132010.","volume":"16","author":"C Tjagvad","year":"2016","journal-title":"BMC Psychiatry."},{"issue":"10","key":"pone.0285583.ref017","first-page":"2477","article-title":"Treatment or \u201chigh\u201d: Benzodiazepine use in patients on injectable heroin or oral opioids.","volume":"38","author":"M Vogel","year":"2013"},{"issue":"4","key":"pone.0285583.ref018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jsat.2009.03.006","article-title":"Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients","volume":"37","author":"M Fats\u00e9as","year":"2009","journal-title":"Journal of substance abuse treatment"},{"issue":"1\u20133","key":"pone.0285583.ref019","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.drugalcdep.2008.07.017","article-title":"Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence","volume":"99","author":"E Lavie","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"pone.0285583.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.04.028","article-title":"Profiles of pregabalin and gabapentin abuse by postmortem toxicology","volume":"241","author":"M H\u00e4kkinen","year":"2014","journal-title":"Forensic Science International"},{"issue":"2","key":"pone.0285583.ref021","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/ajad.12159","article-title":"Prescription medication misuse among opioid dependent patients seeking inpatient detoxification","volume":"24","author":"T Wilens","year":"2015","journal-title":"The American Journal on Addictions"},{"key":"pone.0285583.ref022","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010\u20132014.","author":"TJ Warner M","year":"2016","journal-title":"National vital statistics reports;vol 65 no 10 Hyattsville, MD: National Center for Health Statistics."},{"issue":"2021","key":"pone.0285583.ref023","first-page":"108854","article-title":"Opioid deaths involving concurrent benzodiazepine use: assessing risk factors through the analysis of prescription drug monitoring data and postmortem toxicology","volume":"225","author":"Michael J. Bannon","journal-title":"Drug and Alcohol Dependence"},{"issue":"2021","key":"pone.0285583.ref024","first-page":"e2120353","article-title":"Association between receipt of overlapping opioid and benzodiazepine prescriptions from multiple prescribers and overdose risk","author":"Kao-Ping Chua","journal-title":"JAMA network open 4.8"},{"issue":"4","key":"pone.0285583.ref025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drug abuse and dependence: an examination of reports to the European Medicines Agency database of suspected adverse drug reactions","volume":"22","author":"F Schifano","year":"2019","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"15","key":"pone.0285583.ref026","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2174\/1381612827666210917145636","article-title":"BDZs, designer BDZs and Z-drugs: pharmacology and misuse insights","volume":"28","author":"S Zaami","year":"2022","journal-title":"Current Pharmaceutical Designs"},{"key":"pone.0285583.ref027","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.addbeh.2016.08.020","article-title":"Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder.","volume":"65","author":"RK McHugh","year":"2017","journal-title":"Addictive Behaviors"},{"issue":"3","key":"pone.0285583.ref028","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10550880802122620","article-title":"The Impact of Benzodiazepine Use on Methadone Maintenance Treatment Outcomes","volume":"27","author":"B Brands","year":"2008","journal-title":"Journal of Addictive Diseases"},{"key":"pone.0285583.ref029","author":"EMCDDA","year":"2022","journal-title":"Statistical bulletin 2022- search by country European Monitoring Center for Drugs and Drug Addiction;"},{"key":"pone.0285583.ref030","unstructured":"Socialstyrelsen 2021: Missbruk, substansrelaterade diagnoser och spel om pengar. Tematisk uppf\u00f6ljning av behov, v\u00e5rd och st\u00f6d i f\u00f6rh\u00e5llande till det nationella ANDT-arbetet och spel om pengar. [Alcohol, illicit drugs and gambling. A Thematic Analysis of needs, care and interventions in regard to the national strategy within the area of Alcohol, illicit drugs and gambling. Stockholm: Socialstyrelsen 2021. https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/ovrigt\/2021-4-7277.pdf."},{"key":"pone.0285583.ref031","author":"Socialstyrelsen","year":"2021","journal-title":"Statistik om d\u00f6dsorsaker"},{"key":"pone.0285583.ref032","author":"R\u00e4ttsmedicinalverket","year":"2020","journal-title":"\u00c5rsredovisning"},{"key":"pone.0285583.ref033","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.forsciint.2007.09.012","article-title":"Comparison of ethyl glucuronide in hair with phosphatidylethanol in whole blood as post-mortem markers of alcohol abuse","volume":"176","author":"P. Bendroth","year":"2008","journal-title":"Forensic Sci. Int"},{"key":"pone.0285583.ref034","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1520\/JFS14071J","article-title":"A compilation of fatal and control concentrations of drugs in postmortem femoral blood","volume":"42","author":"H. Druid","year":"1997","journal-title":"J. Forensic Sci"},{"key":"pone.0285583.ref035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.forsciint.2006.08.002","article-title":"Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002\u20132003","volume":"169","author":"A. K. J\u00f6nsson","year":"2007","journal-title":"Forensic Sci. Int"},{"issue":"9","key":"pone.0285583.ref036","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"H. L. Brooke","year":"2017","journal-title":"European journal of epidemiology"},{"issue":"1","key":"pone.0285583.ref037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-019-0354-y","article-title":"Investigating opioid-related fatalities in southern Sweden: contact with care-providing authorities and comparison of substances","volume":"17","author":"L. Andersson","year":"2020","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"pone.0285583.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-021-00351-4","article-title":"Changes in opioid-related deaths following increased access to opioid substitution treatment","volume":"16","author":"L. Andersson","year":"2021","journal-title":"Substance abuse treatment, prevention, and policy"},{"key":"pone.0285583.ref039","volume-title":"[Freedom of choice: an evaluation of patient choice in opioid substitution treatment in Region Sk\u00e5ne].","author":"L. Andersson","year":"2018"},{"issue":"5","key":"pone.0285583.ref040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/dar.12143","article-title":"Opioid\u2010related mortality and filled prescriptions for buprenorphine and methadone","volume":"33","author":"B. N. Wikner","year":"2014","journal-title":"Drug and alcohol review"},{"issue":"7","key":"pone.0285583.ref041","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00127-017-1398-5","article-title":"Drug abuse-associated mortality across the lifespan: a population-based longitudinal cohort and co-relative analysis.","volume":"52","author":"K. S. Kendler","year":"2017","journal-title":"Social psychiatry and psychiatric epidemiology"},{"issue":"4","key":"pone.0285583.ref042","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.","volume":"22","author":"F Schifano","year":"2019","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"2","key":"pone.0285583.ref043","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0376-8716(02)00053-4","article-title":"Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users","volume":"67","author":"SH Heil","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"pone.0285583.ref044","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5694\/mja2.12036","article-title":"Pregabalin misuse-related ambulance attendances in Victoria, 2012\u20132017: characteristics of patients and attendances","volume":"210","author":"R Crossin","year":"2019","journal-title":"The Medical journal of Australia"},{"issue":"10","key":"pone.0285583.ref045","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","article-title":"Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.","volume":"98","author":"G Hajak","year":"2003","journal-title":"Addiction."},{"issue":"1","key":"pone.0285583.ref046","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-015-0037-2","article-title":"Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.","volume":"12","author":"T Richert","year":"2015","journal-title":"Harm Reduction Journal"},{"key":"pone.0285583.ref047","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7517-10-27","article-title":"Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden.","volume":"10","author":"T Richert","year":"2013","journal-title":"Harm Reduct J"},{"issue":"4","key":"pone.0285583.ref048","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000104883","article-title":"Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.","volume":"13","author":"A H\u00e5kansson","year":"2007","journal-title":"European addiction research."},{"issue":"1","key":"pone.0285583.ref049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-019-0301-y","article-title":"Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities","volume":"16","author":"B. Johnson","year":"2019","journal-title":"Harm Reduction Journal"},{"key":"pone.0285583.ref050","article-title":"Drug-related deaths in Sweden: estimations of trends, effects of changes in recording practices and studies of drug patterns","author":"H. Leifman","year":"2016","journal-title":"1. uppl.) Stockholm: Centralf\u00f6rbundet f\u00f6r alkohol- och narkotikaupplysning"},{"issue":"1","key":"pone.0285583.ref051","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","article-title":"A Review of Alprazolam Use, Misuse, and Withdrawal.","volume":"12","author":"N Ait-Daoud","year":"2018","journal-title":"J Addict Med."},{"issue":"1","key":"pone.0285583.ref052","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2125.2004.02089.x","article-title":"Alprazolam is relatively more toxic than other benzodiazepines in overdose","volume":"58","author":"L Isbister GK\u2019 O\u2019Regan","year":"2004","journal-title":"British Journal of Clinical Pharmacology"},{"key":"pone.0285583.ref053","author":"JM Grohl","year":"2018","journal-title":"Top 25 Psychiatric Medication Prescriptions for 2013 Psych Central"},{"key":"pone.0285583.ref054","volume-title":"HHS Publication No. (SMA) 13\u20134760, DAWN Series D-39","author":"SAMHSA: Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011:National Estimates of Drug-Related Emergency Department Visits","year":"2013"},{"issue":"1\u20132","key":"pone.0285583.ref055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"JD Jones","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"pone.0285583.ref056","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1300\/J069v24n04_02","article-title":"Co-Consumption of Benzodiazepines in Heroin Users, Methadone-Substituted and Codeine-Substituted Patients","volume":"24","author":"M Backmund","year":"2006","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"pone.0285583.ref057","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0033291719001727","article-title":"New\/emerging psychoactive substances and associated psychopathological consequences.","volume":"51","author":"F Schifano","year":"2021","journal-title":"Psychological Medicine"},{"issue":"3","key":"pone.0285583.ref058","doi-asserted-by":"crossref","first-page":"e2727","DOI":"10.1002\/hup.2727","article-title":"The rise of new psychoactive substances and psychiatric implications: A wide-ranging, multifaceted challenge that needs far-reaching common legislative strategies","volume":"35","author":"R Rinaldi","year":"2020","journal-title":"Human Psychopharmacology"},{"key":"pone.0285583.ref059","doi-asserted-by":"crossref","first-page":"110343","DOI":"10.1016\/j.forsciint.2020.110343","article-title":"Fatal poisoning in drug addicts in the Nordic countries in 2017.","volume":"313","author":"KW Simonsen","year":"2020","journal-title":"Forensic Sci Int"},{"key":"pone.0285583.ref060","doi-asserted-by":"crossref","first-page":"100446","DOI":"10.1016\/j.abrep.2022.100446","article-title":"Tramadol misuse in treatment-seeking adolescents and young adults with problematic substance use\u2013prediction of treatment retention.","volume":"16","author":"E Alm\u00e9r-Herrnsdorf","year":"2022","journal-title":"Addictive Behaviors Reports"},{"issue":"7","key":"pone.0285583.ref061","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jhm.12889","article-title":"Opioids, benzodiazepines, and COVID-19: A recipe for risk","volume":"17","author":"K Kasanagottu","year":"2022","journal-title":"Journal of Hospital Medicine"},{"key":"pone.0285583.ref062","doi-asserted-by":"crossref","first-page":"731297","DOI":"10.3389\/fpsyt.2021.731297","article-title":"Impact of the COVID-19 pandemic on the general mental health in Sweden: no observed changes in the dispensed amount of common psychotropic medications in the region of Scania.","volume":"12","author":"M Wolfschlag","year":"2021","journal-title":"Frontiers in Psychiatry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0285583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T18:05:13Z","timestamp":1685556313000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0285583"}},"subtitle":[],"editor":[{"given":"Simona","family":"Zaami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0285583","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}